|
HS Code |
584553 |
As an accredited 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists never seem to tire of finding new ways to tweak the pyridine ring. A few atoms here and there, and suddenly a familiar scaffold opens up a batch of new possibilities. This is right where 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine steps onto the stage. In my view, appreciating the place and use of this compound comes from digging into what makes each substituent count, how these modifications shape handling in the lab, and what sorts of problems researchers have stepped up to solve with it.
The backbone here, pyridine, has been the go-to landscape for a huge range of chemistry innovations, from pharmaceutical design to materials development. Adding an amino group to position 2 brings an entry point for further chemical changes. The bromo atom sitting at position 3 becomes a convenient handle. This lets chemists explore coupling reactions familiar to those who work with Suzuki or Buchwald–Hartwig protocols. Lay on the trifluoromethyl at position 5 and suddenly solubility changes, bioavailability behaves differently, and, in some cases, electronic properties tilt in favor of harder-to-reach reaction outcomes.
Why does this matter? Anyone who’s worked through a tough series of analogues for drug development knows that a minor change sometimes reshapes everything from yield to the kinds of side products popping up. The balance of these three functional groups creates a blend of electronic push and pull on the pyridine ring. You can see impacts in NMR shifts. More significantly, the reactivity windows swing wider or shut tight depending on your next synthetic step.
Models and grades exist to suit different application needs. In synthetic labs, even slight impurities send projects off the rails. Here, chemists look for a product that goes beyond basic purity numbers. For the 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine, experienced researchers gravitate toward batches proven through repeated use rather than specification sheets alone. TLC profiles, actual HPLC traces from prior runs, and side-by-side comparisons with previous stocks help build real trust in a supplier’s material. I’ve seen teams run small-scale test couplings, comparing one vendor to another, quantifying loss points in each step, before committing to larger-scale work.
Storage and handling present daily challenges. Trifluoromethyl groups have a habit of driving volatility upward. In airtight storage, any accidental exposure to air or humidity can alter not just stability, but downstream behavior in cross-coupling chemistry. Glass vials, properly sealed, and silica gel dessicants remain the order of the day for anyone hoping to avoid revisiting the frustration of failed NMR readouts or ghostly peaks in chromatograms.
This isn’t a compound confined to an obscure back shelf. Medicinal chemists come knocking when the next fluorinated lead needs an electron-rich pivot point. The amino functionality at position 2 jumpstarts further derivatization with acylating agents, carbamates, and other valuable partners. That bromine world brings the chance to set up Suzuki couplings. Anyone chasing a challenging synthetic target knows how critical it is to slot in the right building block.
Pyridine itself crops up everywhere from cancer research to crop protection. But the difference here lies in the fine balance between substituent placement and reactivity. In my experience, even veteran chemists can underestimate the subtle electronic play between the groups on this molecule. Getting a clean transformation or nailing regioselectivity often demands time spent tweaking base concentrations, solvents, and temperatures. The difference between a reaction that just “works” and one that propels a project forward often comes down to the source and quality of this compound.
Looking at other substituted pyridines, the unique mix of bromo and trifluoromethyl separates this product from, say, a 2-amino-5-chloropyridine or a 3-bromo-5-chloropyridine. The trifluoromethyl effect can’t be overstated. It increases metabolic blocking in new drug candidates, changes partition behavior in phase-transfer reactions, and often dial up binding specificity in biological screening. Many fluorinated molecules owe their popularity in medicinal chemistry to these traits.
Bromine as a leaving group stands out for its practicality. Chlorides might be more widely available, but bromides leave faster in typical cross-coupling chemistry under palladium catalysis. For folks looking to maximize coupling yields without investing in exotic catalysts, the bromo makes the difference. The amino group, reactive and versatile, can lead to a range of derivatives. Labs often face a choice between working with nitro or amino precursors at the desired ring position. I’ve heard colleagues debate for days which path to follow, since reduction steps invite more work and greater risk of over-reactions.
Handling is another point. I’ve heard from teams who, after switching to a similar chlorinated pyridine, spent weeks solving solubility problems in their established solvent systems. That trifluoromethyl sticks out, consistently increasing lipophilicity, impacting both synthetic work-up and downstream biological evaluations.
Academic and industrial research labs have embraced building blocks like 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine for programs focusing on kinase inhibitors, anti-infectives, and even candidate materials for electronics. Trifluoromethylated heterocycles have shown up in treatments targeting everything from influenza to solid tumors. Having this single, stable compound in the lab slashes lead times. There’s less time spent building a precursor, more time applying it to late-stage functionalizations—or even combinatorial syntheses.
Powerful effects from fluorine chemistry are well documented. Around 20 percent of all pharmaceuticals and an even higher chunk of agrochemicals leverage trifluoromethyl groups. The difference compared with non-fluorinated relatives rests on metabolic stability, protein-ligand binding, and atmospheric persistence. Regulatory frameworks scrutinize environmental fate, but the productive role such compounds play in innovation remains high.
The unique three-point modification on this particular pyridine ring streamlines the path toward both novel and familiar therapeutic candidates. Structural analogues often require careful, time-consuming synthesis. Supply constraints and the need for customized routes amplify the importance of reliable commercial supplies of intermediates like this one.
Nothing brings a project to a halt like an unreliable batch of starting material. Purity claims and actual performance don’t always align. In some projects, I’ve seen teams confront issues ranging from unreactive residue to persistent baseline noise in analytic runs. ‘White powder’ on a label tells little about actual performance in a microwave-assisted amination or a pressurized cross-coupling.
Laboratory professionals often vet materials across multiple preps, using both instrumental analysis and “show me” chemistry reactions. I’ve witnessed heated arguments over which supplier's batch gave the cleanest crystallization. Sometimes a minor impurity, invisible on basic analysis, disrupts downstream catalytic cycles or clogs up semi-preparative LC equipment. Spending more for a validated, frequently re-tested source has spared many a team from missed deadlines and wasted materials.
Seasoned chemists often ask for documentation behind the numbers—chromatograms, previous batch outcomes, and even anecdotal lab notes. Over time, the community self-polices by word of mouth, sharing stories of failed reactions and unexpectedly smooth runs. The difference between “reagent grade” and “tried-and-true” becomes very real.
Getting hands on a well-characterized batch offers more than peace of mind. Smoother workflows mean more efficient project timelines. I’ve seen lab teams accelerate project cycles, moving from library production to screening with confidence, once the roadblocks of unreliable starting materials disappear.
In multi-step syntheses, a single bad batch sets off a time-consuming chain of troubleshooting. Real discoveries rarely unfold along a straight path, and every cycle saved in back-checking or re-synthesis matters. Teams working with 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine see gains in speed, repeatability, and ultimately in their ability to answer tougher and more promising scientific questions.
Despite strengths, practical use of this compound is not without hurdles. Trifluoromethylated products raise questions about environmental persistence. Current research focuses on tracking degradation products and potential ecotoxicity in soil and water. The drive for greener approaches in both academia and industry pushes chemists to minimize waste, recapture solvents, and work at smaller scales wherever possible.
Handling also requires regular review. Controlling exposure to air and humidity ensures reliable reactivity. I’ve heard tales of whole batches lost from storing vials in less-than-ideal cabinets. The dissipation of active halides, unnoticed until a control reaction fails, means teams need SOPs for both storage and quick access to fresh reference material.
There is always a tightrope to walk between using a compound with high utility and responsibly managing its footprint from synthesis to disposal. Developers of alternative fluorinated reagents continue searching for new routes and more sustainable processes. For now, 2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine stands as a critical, if niche, resource, helping labs break through bottlenecks in synthesis and discovery.
Building confidence in supplies starts with transparency about batch records and practical performance. Labs benefit when they share back success rates, process notes, and even failures with suppliers. Cross-lab collaborations, precompetitive consortia, and online chemical forums all contribute data points that build a safer, more reliable supply chain.
Academic researchers can play a part by publishing details on reaction outcomes and purification methods, not just headline yields. Industrial teams with more resources often invest in parallel testing, comparing several commercial sources across multiple reactions—sharing both their wins and losses at conferences and in peer-reviewed literature. Everybody learns from collective setbacks and breakthroughs.
Markets for advanced chemical building blocks grow fastest where end users have a clear line of communication with suppliers. Chemists spend time on the phone and over email with technical teams, pressing for honest answers about stock rotation, contaminants, and actual storage conditions. This sort of transparency breeds both trust and real improvements in the products that reach the research bench.
Demand for fluorinated building blocks, particularly those combining amino and halide functionality, keeps rising in both pharmaceutical and specialty materials sectors. From my experience in small biotech startups to large pharma environments, pushing beyond yesterday’s limitations comes down to the right combination of creative science, robust starting materials, and open information.
2-Amino-3-Bromo-5-(Trifluoromethyl)-Pyridine isn’t the most famous molecule. It rarely gets a moment in the public spotlight. But it quietly powers the next generation of research—sometimes in unexpected ways. Whether the application involves bioactive targets or functional polymers, having this compound in reach means the difference between lagging behind or staying in front of discovery curves.
In my time, I’ve found that chemists who invest in understanding the subtle tradeoffs behind every functional handle—fluorine, bromine, amino—enjoy fewer roadblocks and more productive research seasons. Crafting the road ahead for chemical innovation often depends on building trust in the building blocks that make it possible. That matters, no matter which corner of the lab or industry you call home.